Two Sigma Securities’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,100
Closed -$1.56M 1796
2024
Q3
$1.56M Buy
13,100
+3,900
+42% +$359K 0.03% 656
2024
Q2
$739K Buy
9,200
+1,300
+16% +$119K 0.01% 1266
2024
Q1
$729K Buy
7,900
+2,000
+34% +$192K 0.01% 1318
2023
Q4
$623K Buy
5,900
+3,500
+146% +$353K 0.01% 1391
2023
Q3
$261K Sell
2,400
-9,200
-79% -$1.02M ﹤0.01% 2073
2023
Q2
$1.25M Sell
11,600
-6,900
-37% -$776K 0.02% 838
2023
Q1
$2.3M Buy
+18,500
New +$2.54M 0.05% 472
2022
Q4
Sell
-12,200
Closed -$1.65M 2615
2022
Q3
$1.65M Sell
12,200
-18,900
-61% -$2.89M 0.05% 432
2022
Q2
$4.64M Sell
31,100
-5,400
-15% -$825K 0.16% 138
2022
Q1
$6.22M Buy
36,500
+34,800
+2,047% +$5.85M 0.22% 93
2021
Q4
$438K Sell
1,700
-10,800
-86% -$2.96M 0.02% 604
2021
Q3
$3.41M Buy
12,500
+11,500
+1,150% +$3.66M 0.1% 175
2021
Q2
$224K Buy
+1,000
New +$189K 0.01% 1206

Other funds holding BNTX

Two Sigma Securities's BNTX Position: Q1 2026 in Review

Two Sigma Securities sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 8,052 shares — an estimated $767K sold.

Two Sigma Securities first reported a position in BNTX in Q4 2020 and held it in 12 quarters. The position peaked at $6.14M in Q3 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Two Sigma Securities reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 8,052 BioNTech shares in Q1 2026, an estimated $767K.
  • Two Sigma Securities first reported a position in BioNTech in Q4 2020 and held it in 12 quarters.
  • Two Sigma Securities's BioNTech position peaked at $6.14M in Q3 2024.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.